Breaking

Archive

Jan 2 results
18:12
18:12

Shortage of Raltegravir Worries Clients on Third Line HIV Treatment drug stockouts 2

Raltegravir, an integrase inhibitor, is used by people living with HIV that are on third-line treatment. It is administered as a tablet, chewable tablet, and as granules for oral suspension, prescribed for decreasing chances of developing Acquired Immunodeficiency Syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer.
15:49
15:49

New Study Assesses Potency of Six Monthly Injection for HIV Prevention Ministry of Health 5 1

This study will be conducted in four districts of Mityana, Masaka, Hoima and Kalangala for a period of six years. According to Dr. Flavia Matovu Kiweewa, a Researcher based at the Makerere University -Johns Hopkins University Research Collaboration, participants will be receiving an injection every after six months.
Jan 2 results